INBP Integrated Biopharma Dashboard

Integrated BioPharma, Inc. engages in the manufacture, distribution, marketing, and sale of vitamins, nutritional supplements and herbal products. It operates through the following segments: Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers. The Branded Proprietary Products segment distributes nutritional products through mass market, grocery, drug and vitamin retailers. The Other Nutraceutical Businesses segment sells private label MDC products, as well as AgroLabs products. The company was founded by E. Gerald Kay in March 1980 and is headquartered in Hillside, NJ.

Company profile

Ticker

INBP

Exchange

NASDAQ

Website

www.ibiopharma.com

CEO

Riva Kay Sheppard / Christina Kay

Incorporated

Delaware

Location

New Jersey

Fiscal year end

Jun 30

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Merck & Co • Allergan • Johnson & Johnson • Abbott Laboratories • Teva- Pharmaceutical Industries • Viatris • Bristol-Myers Squibb • Lilly(Eli) & Co • Warner Chilcott ...

Former names

CHEM INTERNATIONAL INC, INTEGRATED HEALTH TECHNOLOGIES INC

SEC CIK

0001016504

Corporate docs

Articles of Incorporation & Bylaws

IRS number

222407475

INBP stock data

S&P 500

1M 1Y 2Y 5Y

Press releases

Pro users get this 30m faster

Integrated BioPharma Announces Launch of Investors Website

8 Apr 21

Integrated BioPharma Announces Launch of Investors WebsiteHILLSIDE, NJ / ACCESSWIRE / April 8, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announces the launch of an

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2020

12 Feb 21

HILLSIDE, NJ / ACCESSWIRE / February 12, 2021 / Integrated BioPharma, Inc. ((OTCQX: INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2020.

Integrated BioPharma Announces Upgrade to OTCQX

22 Jan 21

HILLSIDE, NJ / ACCESSWIRE / January 22, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP"), upgraded to the OTCQX® Best Market from OTCQB® Venture Market as of today.

OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX

22 Jan 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

12 Feb 21

11 Apr 21

30 Jun 21

Financial summary

Financial statements Chart INBP financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jun 20	Jun 19	Jun 18	Jun 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	43K	43K	43K	43K	43K	43K
Cash burn (monthly)	108.67K	2K	(positive/no burn)	(positive/no burn)	251.33K	(positive/no burn)
Cash used (since last report)	368.66K	6.79K	n/a	n/a	852.66K	n/a
Cash remaining	-325.66K	36.21K	n/a	n/a	-809.66K	n/a
Runway (months of cash)	-3.0	18.1	n/a	n/a	-3.2	n/a

Beta Read what these cash burn values mean

Recent insider trades

INBP insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
4 Nov 20	Dina Masi	Stock Option Common Stock	Grant	Aquire A	No	No	0.65	100,000	65K	100,000
4 Nov 20	Eric J Friedman	Stock Option Common Stock	Grant	Aquire A	No	No	0.65	50,000	32.5K	50,000
4 Nov 20	Christina Kay	Stock Option Common Stock	Grant	Aquire A	No	No	0.65	100,000	65K	100,000
4 Nov 20	Sheppard Riva	Stock Option Common Stock	Grant	Aquire A	No	No	0.65	100,000	65K	100,000

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: comply, decision, difficult, Fargo, governance, grant, Group, INBP, Notice, notified, OTC, OTCQB, OTCQX, pandemic, paused, Procedural, qualitative, quantitative, quotation, resume, review, SBA, Small, submit, symbol, technical

Removed: converted, convertible, partially

From filing 10-Q 2021 Q2